Expanding cell and gene therapy trials into Europe presents challenges in regulatory compliance, import procedures, product handling and clinical supply. Andelyn and PQP Group have partnered to coordinate manufacturing, Qualified Person certification... Read more
Inherited retinal diseases such as Usher syndrome and Stargardt disease remain difficult to treat, particularly when the genes involved are too large for conventional gene therapy delivery systems. AAVantgarde is advancing its dual-AAV platform throu... Read more
Developing effective drug formulations remains a major challenge for biopharma companies, particularly for molecules with poor solubility or complex release requirements. Quotient Sciences is exploring how machine learning and integrated manufacturin... Read more
Bringing microbiome-based therapies to patients requires more than promising clinical results. Manufacturing complex mixtures of live bacteria consistently and at commercial scale remains a major challenge. MRM Health is addressing this through its p... Read more
Bavarian Nordic A/S (OMX: BAVA) launches the second tranche of the share buy-back program announced on August 21, under which the Company intends to repurchase own shares for up to DKK 750 million. The second tranche will comprise buy-back of shares ... Read more
ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of the second close of its seed financing round, securing an additional €1.6 million, bringing... Read more
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastructure, scientific ... Read more
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, announced a clinical trial collaboration and supp... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.